Artesunate shows potent anti-tumor activity in B-cell lymphoma

被引：0
作者：
Thea Kristin Våtsveen
Marit Renée Myhre
Chloé Beate Steen
Sébastien Wälchli
Ole Christian Lingjærde
Baoyan Bai
Pierre Dillard
Theodossis A. Theodossiou
Toril Holien
Anders Sundan
Else Marit Inderberg
Erlend B. Smeland
June Helen Myklebust
Morten P. Oksvold
机构：
[1] Oslo University Hospital-Radiumhospitalet,Department of Cancer Immunology, Institute for Cancer Research
[2] University of Oslo,Centre for Cancer Biomedicine
[3] Oslo University Hospital-Radiumhospitalet,Department of Cellular Therapy, Department of Oncology
[4] University of Oslo,Department of Computer Science
[5] Oslo University Hospital-Radiumhospitalet,Department of Radiation Biology, Institute for Cancer Research
[6] Norwegian University of Science and Technology,Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences
[7] St. Olav’s Hospital HF,Department of Hematology
来源：
Journal of Hematology & Oncology | / 11卷
关键词：
Artemisinin; B-cell lymphoma; Drug screen; ER stress; UPR;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 281 条
[41]  
Chu R(2016)Artemisinin-derived dimer ART-838 potently inhibited human acute leukemias, persisted in vivo, and synergized with antileukemic drugs Oncotarget 7 7268-undefined
[42]  
Wang H(2007)Calreticulin exposure dictates the immunogenicity of cancer cell death Nat Med 13 54-undefined
[43]  
Ho WE(2013)Immunogenic cell death in cancer therapy Annu Rev Immunol 31 51-undefined
[44]  
Peh HY(undefined)undefined undefined undefined undefined-undefined
[45]  
Chan TK(undefined)undefined undefined undefined undefined-undefined
[46]  
Wong WS(undefined)undefined undefined undefined undefined-undefined
[47]  
Krishna S(undefined)undefined undefined undefined undefined-undefined
[48]  
Ganapathi S(undefined)undefined undefined undefined undefined-undefined
[49]  
Ster IC(undefined)undefined undefined undefined undefined-undefined
[50]  
Saeed ME(undefined)undefined undefined undefined undefined-undefined
12345678910